Assenagon Asset Management S.A. Sells 15,589 Shares of Integer Holdings Corporation $ITGR

Assenagon Asset Management S.A. lowered its stake in Integer Holdings Corporation (NYSE:ITGR) by 30.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,760 shares of the medical equipment provider’s stock after selling 15,589 shares during the period. Assenagon Asset Management S.A. owned approximately 0.10% of Integer worth $3,695,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Russell Investments Group Ltd. raised its stake in Integer by 14.7% during the 1st quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider’s stock valued at $796,000 after purchasing an additional 863 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Integer during the 1st quarter worth about $193,000. SVB Wealth LLC acquired a new position in shares of Integer during the first quarter valued at about $35,000. Magnetar Financial LLC bought a new stake in shares of Integer in the first quarter valued at about $680,000. Finally, The Manufacturers Life Insurance Company grew its position in Integer by 40.2% during the first quarter. The Manufacturers Life Insurance Company now owns 213,741 shares of the medical equipment provider’s stock worth $25,224,000 after buying an additional 61,273 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on ITGR shares. Wells Fargo & Company reissued an “equal weight” rating and issued a $80.00 target price (down previously from $132.00) on shares of Integer in a research note on Friday, October 24th. Piper Sandler decreased their price objective on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Citigroup upped their price objective on Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Argus downgraded Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $95.00 price target (down previously from $143.00) on shares of Integer in a research note on Friday, October 24th. Four research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $98.38.

Insider Activity at Integer

In related news, Director Cheryl C. Capps bought 1,600 shares of Integer stock in a transaction dated Thursday, November 6th. The shares were bought at an average cost of $66.70 per share, with a total value of $106,720.00. Following the acquisition, the director owned 11,702 shares in the company, valued at $780,523.40. This trade represents a 15.84% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Tommy P. Thomas sold 884 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total transaction of $62,012.60. Following the sale, the vice president directly owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. This trade represents a 19.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders bought 5,843 shares of company stock valued at $384,771 in the last 90 days. Insiders own 2.16% of the company’s stock.

More Integer News

Here are the key news stories impacting Integer this week:

• Neutral Sentiment: Multiple law firms are soliciting potential lead plaintiffs and reminding investors of the Feb. 9, 2026 deadline to file in the class action covering purchases from July 25, 2024 to Oct. 22, 2025; this is procedural but increases public attention and potential claimant coordination. Rosen Law Firm notice
• Neutral Sentiment: Other firms (Glancy Prongay & Murray, The Gross Law Firm, Robbins LLP, Bernstein Liebhard, Bronstein Gewirtz & Grossman, BFA and others) have issued similar notices — these increase the probability of active plaintiffs but do not by themselves determine liability or settlement size. Glancy Prongay & Murray deadline alert
• Negative Sentiment: At least one complaint has been filed alleging securities fraud and investor harm tied to Integer and certain executives for the same class period — a filed lawsuit raises litigation exposure, potential settlement or defense costs, and reputational risk. Bronstein Gewirtz & Grossman notice
• Negative Sentiment: One notice highlights that the lawsuit follows a roughly 32% share-price decline, emphasizing investor losses and increasing the attention and potential damages claimed in litigation — this is the main catalyst likely to weigh on sentiment until outcomes become clearer. BFA Law announcement

Integer Stock Performance

ITGR stock opened at $79.23 on Tuesday. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $146.36. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. The firm has a market cap of $2.78 billion, a PE ratio of 33.15, a P/E/G ratio of 0.72 and a beta of 0.82. The business’s 50-day moving average price is $75.40 and its two-hundred day moving average price is $98.15.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Integer announced that its board has authorized a share buyback program on Tuesday, November 4th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 8.3% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.